No Data
China Galaxy Securities: Bullish on the release of restocking demand for chemical products both domestically and overseas in the second half of the year and the sector's earnings improvement; recommends paying attention to the allocation value of the chem
We are optimistic about the release of restocking demand for chemical products both domestically and overseas in the second half of 2026, as well as the sector's improving earnings, and recommend paying attention to the allocation value of the chemical sector.
Adisseo (600299): Temporary pressure on the company's profitability; core projects and specialty product expansion to drive long-term growth.
Event: On March 7, 2026, Adisseo released its annual report for the year 2025. The company's operating revenue for 2025 was RMB 17.231 billion, representing a year-on-year increase of 10.92%. The net profit attributable to shareholders was RMB 1.155 billion.
Huayuan Securities: Supply shock may lead to a continued rise in methionine prices.
The decline in domestic methionine prices since April has mainly been driven by the cooling of sentiment following the U.S.-Iran ceasefire, along with traders' phased shipments.
Adisseo (600299): A globally leading producer of animal nutrition additives, actively promoting its specialty products business.
The latest production capacity enhancement has laid a solid foundation for the company's development. 1) Methionine: The solid methionine project at the Quanzhou plant and related debottlenecking projects at existing facilities are key steps in implementing the 'dual-pillar' strategy, further consolidating the company’s leading position in the methionine industry.
Bluestar Adisseo's Q1 Profit Drops 34%, Revenue Rises 2%
Adisseo (600299): Key projects proceeding smoothly, methionine leader’s capacity continues to increase
Adisseo released its Q1 2026 report: Revenue reached 4.403 billion yuan, a year-on-year increase of 2.42%, while net profit attributable to shareholders was 306 million yuan, a year-on-year decrease of 34.27%. Pressure on prices of functional products led to the decline.